396 related articles for article (PubMed ID: 9135048)
1. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid.
Nakao N; Brundin P
Neuroscience; 1997 Feb; 76(3):749-61. PubMed ID: 9135048
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant treatment protects striatal neurons against excitotoxic insults.
Nakao N; Grasbon-Frodl EM; Widner H; Brundin P
Neuroscience; 1996 Jul; 73(1):185-200. PubMed ID: 8783241
[TBL] [Abstract][Full Text] [Related]
3. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease.
Nakao N; Grasbon-Frodl EM; Widner H; Brundin P
Neuroscience; 1996 Oct; 74(4):959-70. PubMed ID: 8895865
[TBL] [Abstract][Full Text] [Related]
4. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
5. Intrathalamic striatal grafts survive and affect circling behaviour in adult rats with excitotoxically lesioned striatum.
Labandeira-Garcia JL; Liste I; Tobio JP; Rozas G; Lopez-Martin E; Guerra MJ
Neuroscience; 1995 Oct; 68(3):737-49. PubMed ID: 8577370
[TBL] [Abstract][Full Text] [Related]
6. No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy).
Waldner R; Puschban Z; Scherfler C; Seppi K; Jellinger K; Poewe W; Wenning GK
Neuroscience; 2001; 102(3):581-92. PubMed ID: 11226695
[TBL] [Abstract][Full Text] [Related]
7. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies.
Ouary S; Bizat N; Altairac S; Ménétrat H; Mittoux V; Condé F; Hantraye P; Brouillet E
Neuroscience; 2000; 97(3):521-30. PubMed ID: 10828534
[TBL] [Abstract][Full Text] [Related]
8. Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum.
Bowyer JF; Clausing P; Schmued L; Davies DL; Binienda Z; Newport GD; Scallet AC; Slikker W
Brain Res; 1996 Mar; 712(2):221-9. PubMed ID: 8814896
[TBL] [Abstract][Full Text] [Related]
9. Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid.
Araujo DM; Hilt DC
Neuroscience; 1998 Jan; 82(1):117-27. PubMed ID: 9483508
[TBL] [Abstract][Full Text] [Related]
10. Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine.
Petersén A; Hansson O; Puschban Z; Sapp E; Romero N; Castilho RF; Sulzer D; Rice M; DiFiglia M; Przedborski S; Brundin P
Eur J Neurosci; 2001 Nov; 14(9):1425-35. PubMed ID: 11722604
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic grafts implanted into the neonatal or adult striatum: comparative effects on rotation and paw reaching deficits induced by subsequent unilateral nigrostriatal lesions in adulthood.
Abrous DN; Torres EM; Dunnett SB
Neuroscience; 1993 Jun; 54(3):657-68. PubMed ID: 8332254
[TBL] [Abstract][Full Text] [Related]
12. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
[TBL] [Abstract][Full Text] [Related]
13. Effects of alpha-phenyl-N-tert-butyl nitrone and N-acetylcysteine on hydroxyl radical formation and dopamine depletion in the rat striatum produced by d-amphetamine.
Wan FJ; Tung CS; Shiah IS; Lin HC
Eur Neuropsychopharmacol; 2006 Feb; 16(2):147-53. PubMed ID: 16061357
[TBL] [Abstract][Full Text] [Related]
14. Treatment with the spin-trap agent alpha-phenyl-N-tert-butyl nitrone does not enhance the survival of embryonic or adult dopamine neurons.
Karlsson J; Emgârd M; Rosenblad C; Brundin P
Brain Res; 1998 Sep; 805(1-2):155-68. PubMed ID: 9733957
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of unilateral striatal and nigrostriatal lesions on grip strength, skilled paw reaching and drug-induced rotation in the rat.
Jeyasingham RA; Baird AL; Meldrum A; Dunnett SB
Brain Res Bull; 2001 Jul; 55(4):541-8. PubMed ID: 11543955
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-glutamate interactions in the striatum: behaviourally relevant modification of excitotoxicity by dopamine receptor-mediated mechanisms.
Garside S; Furtado JC; Mazurek MF
Neuroscience; 1996 Dec; 75(4):1065-74. PubMed ID: 8938742
[TBL] [Abstract][Full Text] [Related]
17. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
Araujo DM; Hilt DC
Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.
Beal MF; Brouillet E; Jenkins BG; Ferrante RJ; Kowall NW; Miller JM; Storey E; Srivastava R; Rosen BR; Hyman BT
J Neurosci; 1993 Oct; 13(10):4181-92. PubMed ID: 7692009
[TBL] [Abstract][Full Text] [Related]
19. A 'single toxin-double lesion' rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysis.
Ghorayeb I; Fernagut PO; Hervier L; Labattu B; Bioulac B; Tison F
Neuroscience; 2002; 115(2):533-46. PubMed ID: 12421620
[TBL] [Abstract][Full Text] [Related]
20. Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats.
Guyot MC; Palfi S; Stutzmann JM; Mazière M; Hantraye P; Brouillet E
Neuroscience; 1997 Nov; 81(1):141-9. PubMed ID: 9300407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
